| 1 |
32470466 | Reduction in use of cyproterone/ethinylestradiol (Diane-35 and generics) after risk minimization measures in the Netherlands, UK and Italy. | 2020 Oct |
1 |
| 2 |
27769766 | Prescribing of cyproterone acetate/ethinylestradiol in UK general practice: a retrospective descriptive study using The Health Improvement Network. | 2017 Mar |
1 |
| 3 |
28952198 | Thrombotic risk minimization for Diane-35 and generics. | 2017 Nov |
1 |
| 4 |
27098200 | Prescribing patterns of combined hormonal products containing cyproterone acetate, levonorgestrel and drospirenone in the UK. | 2016 Oct |
1 |
| 5 |
12615818 | The risk of venous thromboembolism in women prescribed cyproterone acetate in combination with ethinyl estradiol: a nested cohort analysis and case-control study. | 2003 Mar |
1 |
| 6 |
14558177 | The risk of liver disorders in women prescribed cyproterone acetate in combination with ethinyloestradiol (Dianette): a nested case-control study using the GPRD. | 2003 Oct-Nov |
1 |